KR20100111062A - Composition for decomposing melamine - Google Patents
Composition for decomposing melamine Download PDFInfo
- Publication number
- KR20100111062A KR20100111062A KR1020090029435A KR20090029435A KR20100111062A KR 20100111062 A KR20100111062 A KR 20100111062A KR 1020090029435 A KR1020090029435 A KR 1020090029435A KR 20090029435 A KR20090029435 A KR 20090029435A KR 20100111062 A KR20100111062 A KR 20100111062A
- Authority
- KR
- South Korea
- Prior art keywords
- melamine
- weight
- parts
- composition
- present
- Prior art date
Links
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 title claims abstract description 62
- 229920000877 Melamine resin Polymers 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 36
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims abstract description 26
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims abstract description 26
- 235000013305 food Nutrition 0.000 claims abstract description 21
- 239000008213 purified water Substances 0.000 claims abstract description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 14
- 239000008103 glucose Substances 0.000 claims abstract description 14
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims abstract description 13
- 235000011086 calcium lactate Nutrition 0.000 claims abstract description 13
- 229910001629 magnesium chloride Inorganic materials 0.000 claims abstract description 13
- 229910000027 potassium carbonate Inorganic materials 0.000 claims abstract description 13
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 12
- 229930006000 Sucrose Natural products 0.000 claims abstract description 12
- 239000001527 calcium lactate Substances 0.000 claims abstract description 12
- 229960002401 calcium lactate Drugs 0.000 claims abstract description 12
- 239000001509 sodium citrate Substances 0.000 claims abstract description 12
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 24
- 238000000354 decomposition reaction Methods 0.000 claims description 18
- 239000001103 potassium chloride Substances 0.000 claims description 12
- 235000011164 potassium chloride Nutrition 0.000 claims description 12
- 235000013361 beverage Nutrition 0.000 claims description 9
- 235000011147 magnesium chloride Nutrition 0.000 claims description 7
- 235000011181 potassium carbonates Nutrition 0.000 claims description 7
- 235000011083 sodium citrates Nutrition 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 13
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 8
- 239000011777 magnesium Substances 0.000 description 8
- 229910052749 magnesium Inorganic materials 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000002354 daily effect Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000000593 degrading effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000021067 refined food Nutrition 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000000913 Kidney Calculi Diseases 0.000 description 2
- 206010029148 Nephrolithiasis Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- -1 hydroxide ions Chemical class 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 239000005891 Cyromazine Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000013409 condiments Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000014048 cultured milk product Nutrition 0.000 description 1
- LVQDKIWDGQRHTE-UHFFFAOYSA-N cyromazine Chemical compound NC1=NC(N)=NC(NC2CC2)=N1 LVQDKIWDGQRHTE-UHFFFAOYSA-N 0.000 description 1
- 229950000775 cyromazine Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000024278 histolysis Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000005830 kidney abnormality Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 150000007974 melamines Chemical class 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000020763 muscle atrophy Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100001223 noncarcinogenic Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
- A62D3/32—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents by treatment in molten chemical reagent, e.g. salts or metals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Business, Economics & Management (AREA)
- Emergency Management (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 멜라민 분해용 조성물에 관한 것이다. The present invention relates to a composition for decomposing melamine.
멜라민(melamine)이란 염기성 유기 화합물의 하나로서 C3H6N6의 분자식을 가진 1,3,5-트리아진-2,4,6-트리아민(1,3,5-triazine-2,4,6-triamine)이다. 일반적인 상온의 물에는 약간 녹지만, 수온이 높아지면 비교적 잘 녹는 성향을 가진다. 이러한 멜라민은 시안아미드(cyanamide)의 삼량체 형태를 가지며 시안아미드처럼 질량의 66%가 질소이고, 레진의 성분으로서 소화기에 쓰이는데 그 이유는 연소가 되면 질소를 배출하기 때문이다. 또한 멜라민은 포유동물의 살충제인 시로마진(cyromazine)를 섭취했을 때 체내에서 생성되기도 하는 것으로 알려진 바 있다.Melamine is one of the basic organic compounds, 1,3,5-triazine-2,4,6-triamine having a molecular formula of C 3 H 6 N 6 (1,3,5-triazine-2,4 , 6-triamine). It is slightly soluble in normal room temperature water, but has a tendency to melt relatively well when the water temperature increases. These melamines have a trimer form of cyanamide and, like cyanamide, 66% of its mass is nitrogen and is used in the fire extinguisher as a component of the resin because it emits nitrogen when burned. Melamine has also been known to be produced in the body when ingested with a mammalian insecticide, cyromazine.
한편, 이러한 멜라민은 식품제조 및 가공에 사용할 수 없는 물질로 규정되었는데 이는 일정양 이상을 포유동물이 섭취하였을 경우 독성작용을 하기 때문이며, 특히 많은 양을 섭취하게 되면 요로결석과 방광결석 등을 유발할 수 있다. 또한 많 은 양을 오래 섭취할 경우에는 신장 결함이 일어나 사망에 이르게 된다. 그러나 적은 양의 멜라민은 매일 섭취해도 인체에 해롭지 않다는 것이 전문가들의 주장이다.On the other hand, melamine is defined as a substance that cannot be used in food manufacturing and processing because it is toxic if a mammal ingests a certain amount or more, especially when a large amount is ingested, causing urolithiasis and bladder stones. have. In addition, long-term intake of large amounts of kidney failure will lead to death. But small amounts of melamine aren't harmful to the human body every day, experts say.
일반적으로 비발암 물질에 대해서는 정부 기관에 의해 허용일일 섭취량이 설정되어지는데, 허용일일 섭취량은 평생 동안 매일 섭취해도 아무런 부작용이 없는 섭취량을 말하며 대부분 동물을 이용하여 무유해작용량(NOAER, No Observed Adverse Effect Level)으로 산출된다. 멜라민에 대한 허용일일 섭취량 역시 미국 FDA에 의해 제시되었는데 동물을 이용한 실험결과 신장결석을 유발하지 않는 무유해 작용량은 63 mg/kg/day이다. 이를 사람에게 적용할 때는 보다 안전을 기하기 위해 독성정보에 따라 차이가 있지만 대략 1,000 배 정도 낮추어 허용일일 용량이 설정된다.In general, the allowable daily intake is set by the government agencies for non-carcinogenic substances. The allowable daily intake refers to an intake that has no side effects even if consumed daily for life. Most animals use NOAER (No Observed Adverse Effect). Level). The permissible daily intake of melamine has also been suggested by the US FDA. The results of animal studies show a 63 mg / kg / day harmless dose that does not cause kidney stones. When applied to humans, for safety reasons, the permissible daily dose is set to approximately 1,000 times lower, depending on the toxicity information.
한편, 지난 2006년 중국에서는 단백질의 함량을 속여서 미국으로 수출할 가축 사료의 원료인 밀글루텐 등 조단백 함량이 높은 사료원료의 단백질양을 과장하기 위해 멜라민을 이용하였다. 따라서 이러한 사료를 섭취한 동물이 신장이상으로 사망한 사고가 발생하게 되었고, 급기야 2007년에 이 사료를 전국적으로 회수하는 조치가 이루어졌다.In 2006, melamine was used to exaggerate the amount of protein in foods with high crude protein, such as wheat gluten, which is a raw material for livestock feed to be exported to the United States, by cheating protein. As a result, an accident occurred in which the animals ingesting such feeds died due to kidney abnormalities. In 2007, measures were taken to recover the feeds nationwide.
또한 아직까지 알려지지 않은 물질을 첨가하여 우유내 유단백 함량을 숨기기 위해 중국의 낙농가 또는 우유관련 유업자들이 물로 희석한 멜라민을 첨가하였다. 이러한 이유는 우유에 함유된 질소 함량을 보통의 방법으로 도달할 수 있는 수치 이상으로 높일 수 있기 때문이다. 따라서 이를 섭취한 사람들이 멜라민에 의한 신장 유해 작용으로 인해 지난 2008년 9월 중국에서는 신장결석에 따른 4명의 유아들 이 사망하게 되었고 약 53000명의 소아 환자를 발생시켰다. 이밖에도 멜라민이 유제품과 일상의 우유 및 제과류 등에서도 발견되었다.In addition, melamine diluted with water was added by dairy farmers and milk-related dairy farmers in China in order to hide milk protein content by adding unknown substances. This is because the nitrogen content in the milk can be increased beyond what is normally achieved. Thus, in September 2008, four infants died of kidney stones in China, causing about 53,000 pediatric patients due to melamine's renal adverse effects. Melamine has also been found in dairy products and everyday milk and confectionery.
따라서 멜라민 성분이 안정성 기준을 초과하여 함유된 식품이 최근 다량으로 검출됨에 따라 소비자들의 건강을 위협하고 있는 실정이다.Therefore, as a result of the recent detection of a large amount of food containing melamine components exceeding the safety standards, the situation is threatening the health of consumers.
이에 본 발명자들은 다량의 식품에서 기준함량을 초과하는 멜라민이 검출되어 세계적으로 멜라민 파동이 야기됨에 따라 멜라민을 분해 또는 제거할 수 있는 방법을 개발하던 중, 염화칼륨, 탄산칼륨, 염화마그네슘, 젖산칼슘, 구연산나트륨, 정백당, 정제포도당 및 물을 포함하는 조성물이 멜라민을 효과적으로 분해할 수 있는 효과가 있음을 확인함으로써 본 발명을 완성하였다. Accordingly, the inventors of the present invention are developing a method for decomposing or removing melamine due to the detection of melamine exceeding a reference content in a large amount of food and causing a worldwide melamine wave, and thus, potassium chloride, potassium carbonate, magnesium chloride, calcium lactate, The present invention was completed by confirming that the composition including sodium citrate, white sugar, refined glucose, and water has an effect of effectively degrading melamine.
따라서 본 발명의 목적은 염화칼륨, 탄산칼륨, 염화마그네슘, 젖산칼슘, 구연산나트륨, 정백당, 정제포도당 및 물을 포함하는 멜라민 분해용 조성물을 제공하는 것이다. Accordingly, an object of the present invention is to provide a composition for decomposing melamine comprising potassium chloride, potassium carbonate, magnesium chloride, calcium lactate, sodium citrate, white sugar, refined glucose and water.
또한, 본 발명은 상기 멜라민 분해용 조성물을 이용하여 제조된 식품 또는 음료를 제공하는 것이다. In addition, the present invention is to provide a food or beverage prepared using the composition for degradation melamine.
상기와 같은 본 발명의 목적을 달성하기 위해서, 본 발명은 염화칼륨, 탄산 칼륨, 염화마그네슘, 젖산칼슘, 구연산나트륨, 정백당, 정제포도당 및 물을 포함하는 멜라민 분해용 조성물을 제공한다.In order to achieve the object of the present invention as described above, the present invention provides a composition for decomposing melamine comprising potassium chloride, potassium carbonate, magnesium chloride, calcium lactate, sodium citrate, white sugar, refined glucose and water.
또한, 본 발명은 상기 멜라민 분해용 조성물을 첨가물의 형태로 첨가하여 제조된 식품을 제공한다.In addition, the present invention provides a food prepared by adding the melamine decomposition composition in the form of an additive.
또한, 본 발명은 상기 멜라민 분해용 조성물을 첨가물의 형태로 첨가하여 제조된 음료를 제공한다.In addition, the present invention provides a beverage prepared by adding the melamine decomposition composition in the form of an additive.
본 발명에 따른 염화칼륨, 탄산칼륨, 염화마그네슘, 젖산칼슘, 구연산나트륨, 정백당, 정제포도당 및 물을 포함하는 멜라민 분해용 조성물은 식품제조 과정 중에 기준치 이상으로 함유된 인체 유해 성분인 멜라민을 효과적으로 분해 및 제거할 수 있는 효과가 있으므로 이를 식품 또는 음료의 제조 과정에 사용할 경우 소비자들에게 안전한 식품 또는 음료를 제공할 수 있는 효과가 있다 Melamine decomposition composition comprising potassium chloride, potassium carbonate, magnesium chloride, calcium lactate, sodium citrate, white sugar, refined glucose, and water according to the present invention effectively decomposes and dissolves melamine, which is a harmful component contained in humans, exceeding the standard value during the food manufacturing process. As it can be removed, it can be used to make food or beverages safe for consumers.
본 발명은 염화칼륨, 탄산칼륨, 염화마그네슘, 젖산칼슘, 구연산나트륨, 정백당, 정제포도당 및 물을 포함하는 멜라민 분해용 조성물을 제공한다. 보다 바람직하게는, 50~60℃로 가열한 정제수 100 중량부에 대해 염화칼륨 8~10 중량부, 탄산칼륨 40~60 중량부, 염화마그네슘 1~2 중량부, 젖산칼슘 1~2 중량부, 구연산나트륨 3~7 중량부, 정백당 15~30 중량부 및 정제포도당 2~5 중량부를 포함하는 것을 특징으로 하는 멜라민 분해용 조성물을 제공한다.The present invention provides a composition for decomposing melamine comprising potassium chloride, potassium carbonate, magnesium chloride, calcium lactate, sodium citrate, white sugar, refined glucose, and water. More preferably, 8 to 10 parts by weight of potassium chloride, 40 to 60 parts by weight of potassium carbonate, 1 to 2 parts by weight of magnesium chloride, 1 to 2 parts by weight of calcium lactate, and citric acid to 100 parts by weight of purified water heated to 50 to 60 ° C. It provides a melamine decomposition composition comprising 3 to 7 parts by weight of sodium, 15 to 30 parts by weight per white and 2 to 5 parts by weight of refined glucose.
본 발명의 일실시예에서는 50~60℃로 가열한 정제수 1ℓ를 기준으로 염화칼륨 80~100g, 탄산칼륨 400~600g, 염화마그네슘 10~20g, 구연산나트륨 30~70g, 젖산칼슘 10~20g, 정백당 150~300g 및 정제포도당 20~50g을 첨가하고 용해하여 이온화시킴으로써 멜라민 분해용 조성물을 제조하였다.In one embodiment of the present invention, based on 1 liter of purified water heated to 50 ~ 60 ℃ potassium chloride 80 ~ 100g, potassium carbonate 400 ~ 600g,
본 발명에 따른 멜라민 분해용 조성물을 제조하기 위한 상기 물은 물속에 존재하는 원생생물 및 이물질이 제거되도록 취수원에서 보내진 원수를 당업계에 공지된 방법에 따라 정제할 수 있다. 바람직하게는 여과를 통해 수행할 수 있으며, 더욱 바람직하게는 활성탄 여과조 또는 초정밀 여과 장치를 이용하여 수행할 수 있다. 이후, 여과를 통해 이질이 제거된 정제수에 미네랄 물질들을 용해시켜 본 발명의 조성물을 제조할 수 있으며, 바람직하게는 상기 정제수를 가열하여 사용할 수 있다. 본 발명에 따른 멜라민 분해용 조성물의 제조에 있어서 가열한 정제수를 사용하는 이유는 차가운 정제수를 사용할 경우, 미네랄 성분들이 완전히 용해되지 않은 채 침전물로 남아있을 수 있기 때문이며, 따라서 상기 가열은 혼합된 미네랄 성분들이 침전되지 않을 정도로 정제수를 가열하는 것이 바람직하며, 더욱 바람직하게는 50℃ 내지 60℃의 온도로 가열하는 것이 바람직하다.The water for producing a melamine decomposition composition according to the present invention can be purified according to a method known in the art raw water sent from the intake source to remove the protists and foreign substances present in the water. Preferably, it may be carried out through filtration, and more preferably, it may be performed using an activated carbon filtration tank or an ultra-precision filtration device. Thereafter, the composition of the present invention may be prepared by dissolving mineral substances in purified water from which foreign substances have been removed through filtration, and preferably, the purified water may be heated to be used. The reason for using the heated purified water in the preparation of the melamine decomposition composition according to the present invention is that when cold purified water is used, the mineral components may remain as precipitates without being completely dissolved, and thus the heating is carried out with the mixed mineral components. It is preferable to heat the purified water to such an extent that it is not precipitated, and more preferably to a temperature of 50 ℃ to 60 ℃.
따라서 상기 방법으로 제조된 본 발명의 멜라민 분해용 조성물은 물속에서 이온화되어 알칼리성을 띄는 칼륨, 나트륨, 마그네슘 및 칼슘의 미네랄 성분들을 포함한다.Therefore, the melamine decomposition composition of the present invention prepared by the above method includes mineral components of potassium, sodium, magnesium and calcium that are ionized in water and exhibit alkalinity.
특히, 본 발명에 사용된 미네랄 성분 중 칼륨은 세포내 액의 주된 양이온으 로 세포 외액의 주된 양이온인 나트륨과 함께 삼투압과 수분 평형 조절에 관여하며, 산과 알칼리의 균형 유지에 필수적인 역할을 한다. 그러나 칼륨이 결핍되면 조직분해 또는 설사나 구토 증상이 유발될 수 있으며, 반면 칼륨이 체내에서 과잉 존재 시 갑상선 기능 저하 등을 유발시킬 수 있다. 따라서 본 발명의 조성물은 체내에서 부작용이 없도록 정제수 1000ml에 대하여 염화칼륨을 80~100g 포함하는 것이 바람직하며, 탄산칼륨은 400~600g 포함하는 것이 바람직하다.In particular, potassium in the mineral component used in the present invention is involved in the control of osmotic pressure and water equilibrium together with sodium, the main cation of intracellular fluid, as the main cation of intracellular fluid, and plays an essential role in maintaining the balance between acid and alkali. However, deficiency of potassium can lead to histolysis, diarrhea and vomiting, whereas excess potassium in the body can cause hypothyroidism. Therefore, the composition of the present invention preferably contains 80 to 100 g of potassium chloride with respect to 1000 ml of purified water so that there are no side effects in the body, and preferably contains 400 to 600 g of potassium carbonate.
나트륨은 칼륨과 함께 삼투압을 조절하는 기능이 있고, 세포의 물질교환에 있어서 중요한 역할을 하며, 정상적인 근육의 자극반응 및 흥분성을 유지하는데 관여 한다. 따라서 나트륨이 결핍되면 식욕부진, 소화불량, 근육위축, 장내가스 축적 등의 원인이 될 수 있고, 나트륨이 과도하면 피로, 신경불안증, 발작, 두통 및 잇몸질환 등을 유발시킬 수 있다. 따라서 본 발명의 조성물은 정제수 1000ml에 대하여 구연산나트륨을 30~70g 포함하는 것이 바람직하다.Sodium, together with potassium, functions to regulate osmotic pressure, plays an important role in cell mass exchange, and is involved in maintaining normal muscle irritation and excitability. Therefore, lack of sodium may cause anorexia, indigestion, muscle atrophy, intestinal gas accumulation, etc., and excessive sodium may cause fatigue, nervousness, seizures, headaches and gum disease. Therefore, it is preferable that the composition of this invention contains 30-70 g of sodium citrate with respect to 1000 ml of purified water.
칼슘은 체내의 골격계 유지에 가장 중요한 역할을 하며, 근육의 수축과 이완, 효소 활성화 및 면역과 호르몬의 분비조절에 관여하며, 특히 뼈의 형성에 중요한 역할을 한다. 칼슘 결핍의 경우, 성장부진, 우울증, 불면증 및 각종 통증을 유발시키고, 칼슘의 과잉은 식욕감퇴, 체중감소 및 변비 등을 유발시킨다. 한편, 이러한 칼슘은 물과 매우 격렬하게 반응하기 때문에 일반적으로 알칼리성의 용액 제조에 사용이 불가능하다. 그러나 본 발명에서는 적절한 양의 칼슘을 첨가하여 다른 미네랄 성분들과 함께 단시간에 알칼리성 용액을 만들 수 있게 한다. 따라서 이와 같은 점을 고려하여, 본 발명의 조성물은 정제수 1000ml에 대하여 젖산칼슘을 10~20g 포함하는 것이 바람직하다.Calcium plays the most important role in maintaining the skeletal system in the body, and is involved in muscle contraction and relaxation, enzyme activation and regulation of immunity and hormone secretion. In the case of calcium deficiency, it causes growth, depression, insomnia and various pains, and excessive calcium causes loss of appetite, weight loss and constipation. On the other hand, since such calcium reacts violently with water, it cannot generally be used for the preparation of alkaline solutions. However, in the present invention, an appropriate amount of calcium can be added to make an alkaline solution in a short time with other mineral components. Therefore, in view of such a point, it is preferable that the composition of this invention contains 10-20 g of calcium lactates with respect to 1000 ml of purified water.
마그네슘은 세포 대사에 가장 핵심적인 성분으로써, 효소 활성에 중요한 역할을 하며 골격과 치아를 구성한다. 이러한 마그네슘이 결핍되면 신경과민, 경련, 발작 및 동맥경화 등을 유발시키고, 부족하면 혼수, 구토 및 식욕부진 등을 유발시킨다. 또한 마그네슘은 물속에서 물과 반응하여 마그네슘이 산화됨으로써 수산화이온을 형성하게 되고 형성된 수산화이온에 의해 물은 알칼리성을 띄게 되며 동시에 형성된 수소분자에 의해 환원력을 갖게 된다. 따라서 이러한 마그네슘이 본 발명의 조성물에 너무 많은 양으로 포함될 경우, 물속에서 쉽게 산화마그네슘으로 산화되어 마그네슘 표면에 산화막을 형성하기 때문에 알칼리성을 만드는 능력이 급속이 낮아지게 되며, 반면 너무 적은 양으로 포함될 경우 용액을 알칼리화하는 효과가 미미한 문제점이 있다. 이와 같은 점을 고려하여 본 발명의 조성물은 정제수 1000ml에 대하여 염화마그네슘을 10~20g 포함하는 것이 바람직하다.Magnesium is the most important component of cellular metabolism, plays an important role in enzyme activity and constitutes the skeleton and teeth. Lack of magnesium causes nerve hypersensitivity, convulsions, seizures and atherosclerosis, and lack of magnesium causes coma, vomiting and anorexia. In addition, magnesium reacts with water in water to form hydroxide ions as the magnesium is oxidized, and water is alkaline due to the hydroxide ions formed, and at the same time, it has a reducing power by the hydrogen molecules formed. Therefore, when such magnesium is included in the composition of the present invention in too large a quantity, the ability to make alkalinity is rapidly lowered because it is easily oxidized to magnesium oxide in water to form an oxide film on the surface of magnesium, whereas when included in too small There is a problem that the effect of alkalizing the solution is insignificant. In view of such a point, the composition of the present invention preferably contains 10 to 20 g of magnesium chloride with respect to 1000 ml of purified water.
나아가, 포도당 및 정백당은 이온화된 미네랄 성분들이 재결합하는 것을 방지하여 용액을 안정화시키는 역할을 한다. 따라서 본 발명의 조성물은 정제수 1000ml에 대하여 정백당을 150~300g 포함하는 것이 바람직하고, 정제포도당은 20~50g 포함하는 것이 바람직하다. Furthermore, glucose and white sugar serve to stabilize the solution by preventing the ionized mineral components from recombining. Therefore, it is preferable that the composition of this invention contains 150-300 g of white sugar with respect to 1000 ml of purified water, and 20-50 g of refined glucose is preferable.
본 발명에 따른 멜라민 분해용 조성물은 멜라민 성분을 분해 또는 제거할 수 있는 특징이 있다. 따라서 식품 또는 음료의 제조 과정 중에 기준치 이상의 멜라민 성분이 함유될 경우 이를 섭취한 소비자들에게 발생하는 부작용 및 질환들을 방지할 수 있다.Melamine decomposition composition according to the present invention has a feature that can decompose or remove the melamine component. Therefore, when a melamine component is included in the food or beverage during the manufacturing process, the side effects and diseases occurring to consumers who consume the same may be prevented.
따라서 본 발명에 따른 멜라민 분해용 조성물은 식품 첨가물의 형태로 식품 또는 음료의 제조과정 중에 첨가함으로써 멜라민 성분이 제거 또는 감소된 식품 및 음료를 제조할 수 있다. Therefore, the melamine decomposition composition according to the present invention can be produced during the manufacturing process of food or beverage in the form of food additives to produce a food or beverage with the melamine component removed or reduced.
상기 본 발명에 따른 조성물은 분말, 과립, 정제, 환제, 당의정제, 캡슐제, 액제, 겔제, 시럽제, 슬러리제, 현탁액 및 주사제 등으로 당업계에 공지된 방법을 이용하여 제형화 될 수 있다. The composition according to the present invention may be formulated using a method known in the art as powders, granules, tablets, pills, dragees, capsules, solutions, gels, syrups, slurries, suspensions and injections.
또한, 본 발명의 조성물이 식품의 제조 과정 중에 첨가될 때에는 식품 첨가물의 형태로 식품에 침지, 분무 또는 혼합하여 첨가할 수 있다.In addition, when the composition of the present invention is added during the manufacturing process of the food, it can be added by dipping, spraying or mixing the food in the form of food additives.
상기 식품은 과일, 야채, 과일이나 야채의 건조제품이나 절단제품, 과일쥬스, 야채쥬스, 이들의 혼합쥬스이거나 산성음료수를 포함하는 음료류, 쿠키, 사탕, 카라멜, 껌 등과 같은 제과류, 제빵류, 아이스크림 제품류, 다(茶)류, 요구르트와 같은 발효유식품, 유가공식품, 양념류, 주류, 통조림 또는 병조림류, 면류, 축산가공식품, 수산가공식품, 미생물발효식품, 두류식품, 곡류식품, 육가공류, 감초류, 허브류 중 어느 하나 또는 하나 이상일 수 있다 The foods are fruits, vegetables, dried or cut products of fruits or vegetables, fruit juices, vegetable juices, mixed juices or beverages containing acidic beverages, cookies, candies, caramels, gums, etc. Products, fermented milk products such as tea, yogurt, dairy foods, condiments, alcoholic beverages, canned or bottled foods, noodles, livestock processed foods, fish processed foods, microbial fermented foods, soybean foods, cereals, meat processed foods, licorice Or one or more of herbs
이하, 본 발명을 실시예에 의해 상세히 설명하기로 한다. 그러나 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of examples. However, these examples are intended to illustrate the present invention in more detail, and the scope of the present invention is not limited to these examples.
<실시예 1 내지 3><Examples 1 to 3>
본 발명에 따른 멜라민 분해용 조성물의 제조Preparation of Melamine Decomposition Composition According to the Present Invention
하기 표 1과 같은 조성비로 본 발명에 따른 멜라민 분해용 조성물을 제조하였다. 먼저, 정제수 1000ml을 50~60℃로 가온 유지한 후에, 염화칼륨, 탄산칼륨, 염화마그네슘, 구연산나트륨, 젖산칼슘, 정백당 및 정제포도당을 하기 조성 비율에 맞춰 차례로 넣고 서서히 교반하여 용해시킨 다음, 정치하여 안정화시킨 후 구멍 직경이 0.2㎛인 멤브레인 필터로 여과하여 불순물이 제거된 맑은 연한 미색의 액상 혼합액을 수득함으로써 본 발명의 조성물을 제조하였다. To prepare a melamine decomposition composition according to the present invention in a composition ratio as shown in Table 1. First, 1000 ml of purified water was kept at 50 to 60 ° C., and then potassium chloride, potassium carbonate, magnesium chloride, sodium citrate, calcium lactate, white sugar and refined glucose were added in turn according to the following composition ratio, and gradually stirred to dissolve. After stabilization, the composition of the present invention was prepared by filtering with a membrane filter having a pore diameter of 0.2 μm to obtain a clear pale off-white liquid mixture in which impurities were removed.
<실험예 1>Experimental Example 1
본 발명에 따른 조성물의 멜라민 분해효과 측정Determination of Melamine Degradation Effect of Compositions According to the Present Invention
본 발명에 따른 멜라민 분해용 조성물이 염기성 유기 화합물질인 멜라민(C3H6N6)을 분해하는 효과가 있는지를 조사하였다. 이를 위해 시중에서 판매되고 있는 멜라민을 물에 녹여 1리터에 10ppm의 멜라민 농도가 되도록 하였다. 이후 비이커 5개에 상기 용액을 100ml씩 나눈 뒤, 각 비이커에 본 발명에 따른 조성물을 0.1%(v/v), 0.5%(v/v), 1%(v/v), 2%(v/v) 및 5%(v/v)가 되도록 첨가하였다. 이때 대조군으로는 본 발명의 조성물이 첨가되지 않은 것을 사용하였다. 이후 GC-mass 분석기를 이용하여 각 비이커의 멜라민 함량을 측정하였으며, 그 결과를 하기 표 2 및 도 1에 나타내었다.It was investigated whether the melamine decomposition composition according to the present invention had an effect of degrading melamine (C 3 H 6 N 6 ), which is a basic organic compound. To this end, commercially available melamine was dissolved in water to achieve a melamine concentration of 10 ppm per liter. After dividing the solution into 100 ml each of the five beakers, the composition according to the present invention in each beaker 0.1% (v / v), 0.5% (v / v), 1% (v / v), 2% (v / v) and 5% (v / v). At this time, the control was used was not added to the composition of the present invention. Since the melamine content of each beaker was measured using a GC-mass analyzer, the results are shown in Table 2 and FIG.
조성물의 농도%(v/v)Of the present invention added
% Concentration of composition (v / v)
여기서 멜라민 함량이 1ppm 미만은 식품위생법상 불검출로 표기하였음. Melamine content of less than 1ppm is marked as not detected by the Food Sanitation Law.
그 결과, 상기 표 2에 나타낸 바와 같이, 본 발명에 따른 조성물은 멜라민을 분해하는 효과가 있는 것을 확인할 수 있었으며, 특히 1%의 낮은 농도에서도 멜라민의 함량을 54%나 감소시키는 것으로 나타났고, 5%의 경우에는 멜라민의 함량이 검출되지 않는 것으로 나타났다. 따라서 상기 결과를 통해 본 발명의 조성물은 멜라민을 분해시키는 효과가 매우 우수함을 알 수 있었다(도 4 참조). As a result, as shown in Table 2, it was confirmed that the composition according to the present invention has the effect of degrading melamine, in particular, even at a low concentration of 1% appeared to reduce the content of melamine by 54%, 5 In the case of% no melamine content was detected. Therefore, through the above results, the composition of the present invention was found to have a very good effect of degrading melamine (see Fig. 4).
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far I looked at the center of the preferred embodiment for the present invention. Those skilled in the art will appreciate that the present invention can be implemented in a modified form without departing from the essential features of the present invention. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the present invention is shown in the claims rather than the foregoing description, and all differences within the scope will be construed as being included in the present invention.
도 1은 본 발명에 조성물에 의한 멜라민 분해 효과를 나타낸 그래프이다.1 is a graph showing the melamine degradation effect by the composition in the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090029435A KR20100111062A (en) | 2009-04-06 | 2009-04-06 | Composition for decomposing melamine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090029435A KR20100111062A (en) | 2009-04-06 | 2009-04-06 | Composition for decomposing melamine |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20100111062A true KR20100111062A (en) | 2010-10-14 |
Family
ID=43131438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090029435A KR20100111062A (en) | 2009-04-06 | 2009-04-06 | Composition for decomposing melamine |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20100111062A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107441669A (en) * | 2016-05-31 | 2017-12-08 | 四川大学 | A kind of method of heterogeneous catalysis hydrolysis melamine, cyanuric acid and melamine OAT waste residues |
-
2009
- 2009-04-06 KR KR1020090029435A patent/KR20100111062A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107441669A (en) * | 2016-05-31 | 2017-12-08 | 四川大学 | A kind of method of heterogeneous catalysis hydrolysis melamine, cyanuric acid and melamine OAT waste residues |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20150111724A (en) | Beverage Compositon for Animal Companhaving Antioxidant and Deodorant | |
JP4917584B2 (en) | Processed solubilized bees, method for producing the same, antioxidant, ACE inhibitor, antihypertensive agent, dermal fibroblast proliferation promoter, fatigue recovery agent, blood flow improving agent, and solubilized bees Pharmaceuticals, cosmetics or food / drinks contained | |
KR101113067B1 (en) | Composition for preparing alkali water and method for producing alkali water using the same | |
EP2988614B1 (en) | Lutein composition suitable for infant food formulations | |
KR20100111062A (en) | Composition for decomposing melamine | |
JP2012171899A (en) | Preventing and ameliorating agent for urinary tract infectious disease | |
KR102101381B1 (en) | Manufacturing method for pets feed included kamukamu fruit and the fees therof | |
KR100998991B1 (en) | Enteric-soluble granulation of Cassia obtusifolia L. seeds and the composition for improving constipation containing the same | |
KR20090091653A (en) | Composition for relieving and preventing hangover | |
KR20060083282A (en) | Calcium ion drink that intake uses posible hi-condensed calcium aqueous solution manufacture method and this | |
JP4646550B2 (en) | Mineral-containing agents and their uses | |
KR101598870B1 (en) | Method for preparing functional sugar using jaggery | |
JP2012170342A (en) | Taste quality improver | |
KR20080092045A (en) | The food break up hangover | |
JP2007022968A (en) | Diarrhea ameliorating agent and diarrhea preventive | |
CN110613031A (en) | Apple enzyme fat burning slimming powder and preparation method thereof | |
EP3569070A1 (en) | Capsule containing pyrroloquinoline quinone or salt thereof and branched chain amino acid | |
CN109846910A (en) | A kind of compound lentinan particle conducive to chronic hepatitis and tumor in digestive tract rehabilitation | |
RU2482698C1 (en) | Composition for preparation of alcohol-free jelly beverage | |
CN102488092A (en) | Anti-bacteria mildew-proof fruity type liquid flavoring agent and preparation technology thereof | |
JP4645841B2 (en) | Royal jelly-containing beverage composition | |
JP7296623B2 (en) | α-Amylase activity inhibitor and method for producing α-amylase activity inhibitor | |
RU2450534C2 (en) | Jelly marmalade production method | |
KR20170117559A (en) | A slim and aqua concentrate containing normalized and triple salt stabilized (-) - hydroxycitric acid of Garcinia cambogia extract for the production of weight controlling concentrates and slimming waters and products derived therefrom, ) | |
KR20040064647A (en) | Method for production of solvent for high solution of calcium, calcium powder with high solubility thereof and calcium liquid thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Withdrawal due to no request for examination |